Left Ventricular Assist Devices at the Crossroad of Innovation in Advanced Heart Failure

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Left Ventricular Assist Devices at the Crossroad of Innovation in Advanced Heart Failure. / Mehra, Mandeep R.; Gustafsson, Finn.

In: Journal of Cardiac Failure, Vol. 27, No. 11, 2021, p. 1291-1294.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Mehra, MR & Gustafsson, F 2021, 'Left Ventricular Assist Devices at the Crossroad of Innovation in Advanced Heart Failure', Journal of Cardiac Failure, vol. 27, no. 11, pp. 1291-1294. https://doi.org/10.1016/j.cardfail.2021.06.003

APA

Mehra, M. R., & Gustafsson, F. (2021). Left Ventricular Assist Devices at the Crossroad of Innovation in Advanced Heart Failure. Journal of Cardiac Failure, 27(11), 1291-1294. https://doi.org/10.1016/j.cardfail.2021.06.003

Vancouver

Mehra MR, Gustafsson F. Left Ventricular Assist Devices at the Crossroad of Innovation in Advanced Heart Failure. Journal of Cardiac Failure. 2021;27(11):1291-1294. https://doi.org/10.1016/j.cardfail.2021.06.003

Author

Mehra, Mandeep R. ; Gustafsson, Finn. / Left Ventricular Assist Devices at the Crossroad of Innovation in Advanced Heart Failure. In: Journal of Cardiac Failure. 2021 ; Vol. 27, No. 11. pp. 1291-1294.

Bibtex

@article{a2c6701ac4cb415fb855d45b4396a3df,
title = "Left Ventricular Assist Devices at the Crossroad of Innovation in Advanced Heart Failure",
keywords = "advanced heart failure, early referral, innovation, LVAD, outcomes",
author = "Mehra, {Mandeep R.} and Finn Gustafsson",
note = "Funding Information: Mandeep R. Mehra reports payments made to my institution from Abbott for consulting; Consultant fees from Medtronic, Janssen, Mesoblast, Portola, Bayer, Triple Gene, and Baim Institute for Clinical Research; and Scientific Advisory Board Member for NuPulseCV, Leviticus, and FineHeart. Finn Gustafsson reports consulting honoraria from Abbott, Bayer, Pfizer, Alnylam, Boehringer-Ingelheim, Amgen, Pharmacosmos and Idorisa for consulting and speaker fees from Novartis, Astra-Zeneca, Orion Pharma, and Vifor.",
year = "2021",
doi = "10.1016/j.cardfail.2021.06.003",
language = "English",
volume = "27",
pages = "1291--1294",
journal = "Journal of Cardiac Failure",
issn = "1071-9164",
publisher = "Churchill Livingstone",
number = "11",

}

RIS

TY - JOUR

T1 - Left Ventricular Assist Devices at the Crossroad of Innovation in Advanced Heart Failure

AU - Mehra, Mandeep R.

AU - Gustafsson, Finn

N1 - Funding Information: Mandeep R. Mehra reports payments made to my institution from Abbott for consulting; Consultant fees from Medtronic, Janssen, Mesoblast, Portola, Bayer, Triple Gene, and Baim Institute for Clinical Research; and Scientific Advisory Board Member for NuPulseCV, Leviticus, and FineHeart. Finn Gustafsson reports consulting honoraria from Abbott, Bayer, Pfizer, Alnylam, Boehringer-Ingelheim, Amgen, Pharmacosmos and Idorisa for consulting and speaker fees from Novartis, Astra-Zeneca, Orion Pharma, and Vifor.

PY - 2021

Y1 - 2021

KW - advanced heart failure

KW - early referral

KW - innovation

KW - LVAD

KW - outcomes

U2 - 10.1016/j.cardfail.2021.06.003

DO - 10.1016/j.cardfail.2021.06.003

M3 - Journal article

C2 - 34139365

AN - SCOPUS:85108943699

VL - 27

SP - 1291

EP - 1294

JO - Journal of Cardiac Failure

JF - Journal of Cardiac Failure

SN - 1071-9164

IS - 11

ER -

ID: 301618615